Stocktoria
Cordyceps Sunshine Biotech Holdings Co., Ltd. RAJAF
OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2023-10-09
Cordyceps Sunshine Biotech Holdings Co., Ltd. statistics & valuation
Market cap$577.8M
Net margin-12.4%
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 61.1% | 72.3% | 86.8% | 74.2% | -20.0% |
| Operating margin | -11.3% | -14.7% | 25.8% | -778.8% | -13.6% |
| Net margin | -12.4% | -18.1% | 85.2% | -1350.9% | -55.8% |
| FCF margin | — | -3.0% | 4.6% | -741.6% | -52.9% |
| Return on assets | -3.3% | -4.9% | 22.4% | -34.2% | -15.0% |
| Return on equity | 29.0% | 60.2% | -495.1% | 75.7% | 178.0% |
| Debt / equity | — | — | -2.84× | -0.44× | — |
| Current ratio | 0.19 | 0.12 | 0.11 | 0.20 | 0.39 |
Source: SEC EDGAR filings · CIK 0001885680 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.